









Markets
/
Stocks
/
nasdaq-thc
/

Tenet Healthcare Corp

THC

208.630USD

-0.510-0.24%

Close 10/30, 16:00（ET）Quotes delayed by 15 min

18.33BMarket Cap

13.54P/E TTM



Tenet Healthcare Corp

208.630

-0.510-0.24%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Tenet Healthcare Corp

Currency: USD Updated: 2025-10-29

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tenet Healthcare Corp's Score

Industry at a Glance

Industry Ranking

11 / 78

Overall Ranking

75 / 4623

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 24 analysts

Buy

Current Rating

223.157

Target Price

+9.06%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Tenet Healthcare Corp Highlights

StrengthsRisks

Tenet Healthcare Corporation is a diversified healthcare services company. The Company’s care delivery network includes USPI Holding Company, Inc. (USPI), which operates or has ownership interests in ambulatory surgery centers and surgical hospitals. The Company also operates acute care and specialty hospitals, as well as other outpatient facilities, including surgical hospitals, and ambulatory surgery centers (ASC), among others. The Company operates through two segments: Hospital Operations and Services, and Ambulatory Care. The Hospital Operations and Services segment, which is comprised of acute care and specialty hospitals, a network of employed physicians and ancillary outpatient facilities, as well as the revenue cycle management and value-based care services that the Company provide to hospitals, health systems, physician practices, employers, and other clients. The Ambulatory Care segment, which is comprised of USPI’s ASCs and surgical hospitals.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 20.66B.

Fairly Valued

The company’s latest PE is 14.10, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 88.41M shares, decreasing 12.68% quarter-over-quarter.

Held by Larry Robbins

Star Investor Larry Robbins holds 2.93M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.30.

Financial Health

Currency: USD Updated: 2025-10-29

The company's current financial score is 7.70, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 5.27B, representing a year-over-year increase of 3.29%, while its net profit experienced a year-over-year increase of 11.20%.

Score

Industry at a Glance

Previous score

7.70

Change



Financials

9.11

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.20

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.08

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.74

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

6.34

Key Metrics

Free cash flow

No Data

Tenet Healthcare Corp's Company Valuation

Currency: USD Updated: 2025-10-29

The company’s current valuation score is 6.02, which is lower than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 14.10, which is 47.02% below the recent high of 20.73 and 75.35% above the recent low of 3.47.

Score

Industry at a Glance

Previous score

6.02

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 11/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-29

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Providers & Services industry's average of 7.60. The average price target for Tenet Healthcare Corp is 230.00, with a high of 260.00 and a low of 159.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 24 analysts

Buy

Current Rating

225.430

Target Price

+7.79%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Tenet Healthcare Corp

THC

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Natera Inc

NTRA

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-29

The company’s current price momentum score is 9.22, which is higher than the Healthcare Providers & Services industry's average of 7.13. Sideways: Currently, the stock price is trading between the resistance level at 221.82 and the support level at 192.06, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.88

Change

0.34

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.821

Buy

RSI(14)

58.680

Neutral

STOCH(KDJ)(9,3,3)

58.026

Sell

ATR(14)

6.414

High Vlolatility

CCI(14)

85.963

Neutral

Williams %R

29.592

Buy

TRIX(12,20)

0.287

Sell

StochRSI(14)

19.740

Oversold

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

209.786

Sell

MA10

206.542

Buy

MA20

202.130

Buy

MA50

195.266

Buy

MA100

181.493

Buy

MA200

160.095

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-29

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 100.07%, representing a quarter-over-quarter decrease of 4.96%. The largest institutional shareholder is The Vanguard, holding a total of 9.44M shares, representing 10.74% of shares outstanding, with 1.61% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

9.44M

-4.60%

BlackRock Institutional Trust Company, N.A.

7.79M

-3.06%

Fidelity Management & Research Company LLC

7.64M

-2.76%

T. Rowe Price Associates, Inc.

Star Investors

7.06M

-4.70%

Glenview Capital Management, LLC

Star Investors

2.93M

-13.69%

State Street Investment Management (US)

2.88M

-4.72%

Boston Partners

2.27M

+95.00%

Geode Capital Management, L.L.C.

2.16M

-1.94%

Columbia Threadneedle Investments (US)

2.12M

+8.35%

Invesco Advisers, Inc.

1.98M

-18.38%

Risk Assessment

Currency: USD Updated: 2025-10-29

The company’s current risk assessment score is 7.62, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 1.52. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.